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ABSTRACT PAGE
Previous studies have shown that muscarinic receptor blockade decreases signal detection
in a sustained attention task that requires discrimination of visual signals from trials with no
signal presentation. However, the exact role of specific muscarinic receptor subtypes in
attentional performance remains unclear. The present experiments examined the effects of
blocking M1 receptors on attentional performance in rats. Rats were trained in a two-lever
sustained attention task that required discrimination of visual signals (500, 100, 25 ms) from
“blank” trials when no signal was presented. In Experiment 1, rats received the M1 receptor
antagonist, dicyclomine (0, 0.625, 1.25, 2.5, and 5.0 mg/kg; ip), prior to performance in this
task and prior to performing the task with a houselight flashing throughout the session or
with a shorter intertrial interval. Dicyclomine (5.0 mg/kg) decreased the detection of signals
in the standard task when compared to vehicle. Similarly, accuracy was decreased following
5.0 mg/kg dicyclomine compared to vehicle with a shorter intertrial interval, however, the
deficit was only observed following the 100 ms signal. In the distracter task, when vehicle
was compared to drug treatment, animals exhibited significant signal detection deficits at
lower doses compared to the standard task. In Experiment 2, a guide cannula was surgically
implanted into either the right or left ventricle of rats after reaching stable performance
levels. All animals received infusions of the M1 receptor antagonist, pirenzepine (0, 10, 30,
and 60 pg) prior to performing the standard attention task. Pirenzepine decreased accuracy
of detecting the 500 ms signal following the highest dose (60 pg) when compared to vehicle.
The lack of effects of dicyclomine and pirenzepine on trials with no signal presentation or on
omissions suggests that M1 receptor blockade does not disrupt motoric functioning,
motivation or the ability to respond based upon the rules of the task. The present results
suggest that M1 receptors critically contribute to attentional processing mediated by the
central cholinergic system.
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Blockade o f muscarinic M l receptors disrupts performance in an attentiondemanding visual discrimination task
Attention has been described as the ability to detect and select stimuli for
further processing (Knudsen, 2007). Attention is carried out by a network of
anatomical areas, as opposed to a single brain region or a general function of the
brain operating as a whole (Posner & Peterson, 1990). Neurological models of
attention have differentiated separate subcomponents of attention, such as
sustained attention and selective attention, which can be defined functionally and
to some extent, anatomically. Vigilance or sustained attention concerns the ability
o f observers to maintain attention and remain alert to stimuli over prolonged
periods o f time (Parasuraman, Warm, & Dember, 1987). Being able to sustain
attention is a critical behavioral adaptation because it is a basic requirement for
the acquisition and recall o f information (Sarter, Bruno, & Givens, 2003). The
attentional system warrants further investigation because disruptions in this
system could impair learning and memory, possibly contributing to deficits in
some neuropsychiatric diseases including Alzheimer’s disease.
Attentional deficits in Alzheimer’s disease
Deficits in attention have been associated with the early stages o f
Alzheimer's disease (AD) (Perry & Hodges, 1999). Cholinergic neuron loss is
thought to underlie the cognitive impairments seen in AD and provides the
rationale for cholinergic replacement pharmacotherapies (Bartus, Dean, Beer, &
Lippa, 1982). Based on the cholinergic hypothesis, acetylcholinesterase inhibitors
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(AChE-Is) have emerged as the main therapeutic agents in treating AD. The
AChE-Is act on the acetylcholine (ACh) pathway by inhibiting the enzyme
acetylcholinesterase, which is normally responsible for hydrolysis o f ACh. AChEIs have been found to improve, or at least slow deterioration for some aspects of
cognitive performance in patients with AD (Rogers, Farlow, Doody, Mohs, &
Friedhoff, 1998). Systemic drug administration o f an ACh-I, donepezil, has been
found to enhance cognitive function (Rogers et al., 1998) including attentional
performance (Salloway et al., 2004) in patients with mild to moderate AD.
Several long-term clinical trials with AChE-Is have reported that these drugs
actually decrease the rate o f cognitive decline, and may delay the disease
progression by 1 to 2 years (Farlow, 2002) but the benefits are modest (Courtney
et al., 2004). AChE-Is are unable to slow progression from mild cognitive
impairment to dementia (Raschetti, Albanese, Vanacore, & Maggini, 2007).
While AChE-Is are the best current option for the treatment o f AD, a drug that is
more selective to the particular cholinergic receptors affected by the disease may
be better at treating the symptoms and slowing the progression o f the disease.
AChE-Is act to increase the level and duration of ACh in the synapse so ACh can
bind to all cholinergic receptors. A better understanding of the cholinergic
receptors involved in attention may allow the development o f more targeted drugs
to provide maximal attention-related benefits via the cholinergic system.
There is evidence to support the hypothesis that cognitive disturbances
associated with AD are due to disruptions in the cholinergic system (Auld,
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Komecook, Bastianetto, & Quirion, 2002). Neurons of the basal forebrain
undergo a profound and selective degeneration in AD patients which leads to a
cholinergic deficiency in their brains (Bartus et al., 1982; Whitehouse et al., 1982).
While the behavioral effects o f ACh on the brain have been extensively
characterized by administering cholinergic drugs to human subjects, animal
experiments have provided further insight into the function of the cholinergic
system through controlled experiments. However, the assessment o f attention in
animals needs to be carefully considered before applying manipulations o f brain
function.
Measuring attention in the rat
A taxonomy for sustained attention has been developed to understand the
different task parameters that can affect performance (Parasuraman et al., 1987).
According to this taxonomy, one factor that contributes to sustained attentiondemanding tasks is the event rate. Events that are presented quickly or at a
variable rate have been shown to disrupt performance in tests o f sustained
attention (Parasuraman et al., 1987). Another important dimension that places
demands on sustained attention is whether signals and nonsignals are presented
successively (successive discrimination) from a single location. Successive
discrimination places additional demands on the animal because signals have to
be distinguished from a nonsignal reference represented in recent memory
(Parasuraman et al., 1987). The use o f dynamic stimuli, such as signals with
variable duration also increases attentional load because they are more difficult to
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discriminate (McGaughy & Sarter, 1995). Taking these factors into consideration,
McGaughy and Sarter (1995) modified a task by Bushnell, Kelly, and Crofton
(1994) to develop an attention-demanding two-lever task that required rats to
discriminate between successively presented signals and nonsignals. The task
includes several features (competing response rules, variable signal duration, and
variable intertrial interval (ITI)) that impose a cognitive load, ensuring that even
the basic version o f the task cannot be successfully completed on the basis o f side
biases or simple response timing. The task instead requires directed attention to
the presence or absence o f brief visual stimuli on each trial. Distraction (in the
form o f a flashing houselight) (Gill, Sarter, & Givens, 2000; Himmelheber, Sarter,
& Bruno, 2000) and decreasing the time between signal and nonsignal events
(short ITI) (McGaughy & Sarter, 1995) can be introduced to challenge
performance and increase attentional demands. The development o f this task has
allowed for more in depth research o f attention because it improves upon previous
tasks that did not provide a valid measure o f the subjects’ ability to discriminate
between signal and nonsignal events. In previous tasks, baseline lever pressing
rates could confound the false alarm rate (McGaughy & Sarter, 1995).
Specifically, previous tasks had a lever extended throughout the session and
animals were trained to press the lever after a stimulus (e.g., a brief light) was
presented. Lever presses in the absence of the light were considered false alarms.
However, any manipulation (e.g, drug treatment) that influences baseline lever
pressing rate would be expected to impact the false alarm rate. Thus, it was
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difficult to establish whether changes in the false alarm rate reflected changes in
signal processing or the baseline lever pressing rate. The modified task prevents
spontaneous lever pressing because the levers are only extended after a signal or
nonsignal event and are retracted during the ITI.
Basal forebrain cholinergic system
The basal forebrain is a collection of structures that lie near the bottom o f
the anterior portion of the brain, ventrally to the striatum that includes the nucleus
basalis of Meynert, diagonal band of Broca, and medial septal nuclei (Mesulam,
Mufson, Wainer, & Levey, 1983). Collectively, from these structures within the
basal forebrain, cholinergic neurons send projections widely throughout the brain,
including to the amygdala, thalamus, cortical mantle, hippocampal formation, and
the olfactory bulb (Mesulam et al., 1983).
Experiments that have selectively damaged the basal forebrain have been
used for elucidating the function o f this structure, particularly with regard to
cognitive processing. Excitotoxic lesions of the basal forebrain have been shown
to decrease accuracy on a five-choice serial reaction time task which is designed
to assess multiple aspects of cognition, such as sustained attention and impulsivity
(Muir, Everit, & Robbins, 1994). Tasks that place explicit demands on attentional
processes rather than learning and memory appear particularly sensitive to lesions
o f the basal forebrain (Voykto et al., 1994). The development o f a selective
cholinergic immunotoxin, 192 IgG-saporin, has provided further support for the
role o f the basal forebrain corticopetal cholinergic neurons in attention
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(McGaughy, Everitt, Robbins, & Sarter, 2000). 192 IgG is an antibody to the rat
p75 nerve growth receptor. This antibody can be coupled to saporin, a ribosomeinactivating protein that causes cell death (Wiley, Oeltmann, & Lappi, 1991). 192
IgG-saporin, specifically targets and destroys cortically-projecting cholinergic
neurons o f the basal forebrain, the only neurons in the basal forebrain that express
the p75 nerve growth factor receptor (Wiley et al., 1991). McGaughy, Kaiser, &
Sarter (1996) found that intrabasalis infusions o f 192 IgG-saporin decrease signal
detection in a sustained attention task. In a separate experiment employing a fivechoice serial reaction time task, intrabasalis infusions o f high or low doses of 192
IgG-saporin produced different degrees o f damage that correlated with the degree
o f accuracy deficit (McGaughy, Dailey, Morrison, Everitt, & Robbins, 2002).
Furthermore, the accuracy deficit was significantly correlated with a reduction in
cortical ACh efflux in rats with extensive lesions only.
Although cortical cholinergic inputs are critical for maintaining attentional
performance they are o f particular importance under conditions o f increased
attentional demands. Burk, Lowder, and Altemose (2008) found that loss of basal
forebrain corticopetal cholinergic neurons can decrease signal detection in a
sustained attention task, but only under conditions when multiple aspects of the
task are attention-demanding. Animals were initially trained with minimal
attentional demands and then following loss o f cortical cholinergic inputs the task
parameters were altered to increase attentional demands. No single task
parameter disrupted signal detection following loss of basal forebrain corticopetal
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cholinergic neurons, but signal detection was disrupted under conditions when
multiple aspects of the task were attention-demanding. Thus, cortical ACh is
critical for attentional effort or the recruitment o f attentional mechanisms in
response to challenges (Sarter, Gehring, & Kozak, 2006).
Cortical ACh and attention
Cortical ACh release is more highly elevated in rats performing a
sustained attention task compared with control tasks (Arnold, Burk, Hodgson,
Sarter, & Bruno, 2002; Passetti, Dailey, O'Connell, Everitt, & Robbins, 2000).
Studies assessing cortical ACh release in attentional task-performing rats have
generated preliminary evidence suggesting that increased demands on sustained
attention performance are associated with increases in cortical ACh efflux
(Himmelheber et al., 2000). ACh efflux in the frontoparietal cortex was studied
with in vivo microdialysis while rats performed in an operant task designed to
assess sustained attention (Himmelheber et al., 2000). A visual distracter was
used during task performance to increase attentional demands. When animals
performed under increased attentional demands there was an increase in cortical
ACh efflux. The authors speculate that the effects of the distracter on
performance and cortical ACh efflux were due to its ability to increase
background noise and disrupt active attentional processing. This finding extends
hypotheses regarding the crucial role o f cortical cholinergic transmission for
attentional functions. The effects of the distracter stimulus provide evidence for a
direct relationship between attentional effort and cortical ACh release.
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Recent evidence from studies employing choline-sensitive biosensors
suggest that ACh regulates attentional processing on multiple time scales,
involving a tonic component that relates more to arousal and a phasic component
that appears to contribute more to cue detection (Parikh, Kozak, Martinez, &
Sarter, 2007). These studies support the general hypothesis that cortical
cholinergic inputs, while not exclusively mediating attentional processes, are
likely to be activated by behavioral situations taxing attentional capabilities.
Muscarinic receptors
ACh binds to both muscarinic and nicotinic cholinergic receptors (Cooper,
Bloom, & Roth, 2003). The blockade o f muscarinic receptors, but not nicotinic
receptors, disrupts attentional performance in monkeys (Herrero et al,, 2008) and
in rats (Johnson & Burk, 2006; McQuail & Burk, 2006). Muscarinic receptors
belong to a class o f metabotropic receptors which use G proteins as their signaling
mechanism (Cooper, et al., 2003). Muscarinic acetylcholine receptors are
involved in memory and attention (Broks et al., 1988), and it is hypothesized that
a muscarinic agonist could provide a replacement therapy in AD. However, the
exact role of specific muscarinic receptor subtypes in attentional performance
remains unclear. Five different muscarinic receptor subtypes (M1-M5) have been
identified. In terms o f a role in cognitive processing, most research has assessed
the contributions o f M l and M2 receptors. M l receptors are primarily postsynaptic receptors and M2 receptors are pre-synaptic autoreceptors, which act to
negatively modulate acetylcholine release (Clader & Wang, 2005). Muscarinic
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receptor blockade produces cognitive impairments (McQuail & Burk, 2006), and
it is thought that these effects most likely involve M l receptors because M2
receptor blockade would be expected to increase acetylcholine release. M2
receptors have also been shown to decline in AD brains while M l receptor levels
remained unchanged (Flynn, Ferrari-DiLeo, Levey, & Marsh, 1995). With
decreasing levels of M2 receptors there may not be adequate neural substrate for
M2 receptor antagonists to act upon for treating age- and dementia-related
cognitive decline. Because M l receptors are retained it makes the M l receptor an
attractive target for symptomatic treatment of AD. This approach is further
supported by muscarinic M l receptor agonists that have improved performance
on cognitive tests in Alzheimer’s patients (Bodick, et al., 1997) and cognition in
animal models o f the disease (Fisher, Brandeis, Chapman, Pittel, & Michaelson,
1998; Genis, Fisher, & Michaelson, 1999). Furthermore, impairment o f M l
mediated signaling may underlie the cognitive decline o f AD via effects on
protein kinase C activity and NMDA receptor density (Tsang et al., 2007).
Muscarinic M l receptor agonists have been shown to enhance learning
and memory in animals. The muscarinic M l receptor agonists, arecholine,
pilocarpine, and McN-A-343, facilitated learning acquisition in an activeavoidance paradigm in rats which records an anticipatory conditioned avoidance
apart from the classical conditioned avoidance response (Sen & Bhatacharya,
1991). This learning enhancement was later attenuated by the selective M l
antagonist, pirenzepine. In addition, M l receptor agonists have been found to
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significantly reduce age-related cognitive impairments (Brandeis, Dachir, Sapir,
Levy, & Fisher, 1990). Memory functions were impaired in the Morris Water
Maze and 8-arm radial arm maze in aged rats compared to young animals. The
administration of AF102B, an M l receptor agonist, significantly reduced the agerelated cognitive impairments observed in both tasks. The ability o f muscarinic
M l receptor agonists to enhance performance in these memory tasks may result
from improved attention capacity that can aid in the acquisition of spatial
navigation strategies (Aura, Sirvio, & Riekkinen Jr., 1997). These data support
the hypothesis that enhancement of cholinergic function may reverse geriatric
cognitive deficits.
Not surprisingly, M l receptor antagonists have been found to disrupt
cognitive performance. Pirenzepine, an M l receptor antagonist, disrupted spatial
memory (Bymaster, Heath, Hendrix & Shannon, 1993), as well as performance
accuracy on a delayed non-matching to position task (Aura et al., 1997). Mice
with a mutation of the gene coding for the M l receptor showed impaired working
memory on the radial arm maze as well as impaired acquisition and consolidation
of contextual fear conditioning (Anagnostaras et al., 2003). This finding suggests
that the M l receptor is specifically involved in memory processes for which the
cortex and hippocampus interact. Collectively, these data support the idea that the
M l receptor is critical in cognitive processing.
Despite the evidence that muscarinic M l receptors are involved in
memory, the role o f these receptors in attentional functioning has not been
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thoroughly investigated. Although it has been suggested that M l receptors are
critical for attentional performance there are currently no studies that examine the
role of the M l receptor in an attention demanding task. The present experiments
were designed to investigate the hypothesis that muscarinic M l activation is
necessary for performance in an attentional task. Experiment 1 examined the
effects of systemic administration o f dicyclomine, an M l receptor antagonist, on
attentional performance in rats. A previously validated attention task designed to
place high demands on attentional processing (e.g., brief and variable signal
durations and ITIs) and that required the discrimination o f a brief visual signal
from trials with no signal presentation was used. Furthermore, Experiment 1
investigated the role o f the M l receptor when attentional demands were increased.
Accuracy on the task has been previously shown to decrease when background
noise is increased by flashing a houselight as well as when the ITI is decreased
(McGaughy & Sarter, 1995). M l receptor blockade is hypothesized to
differentially disrupt performance when attentional demands are increased. In
Experiment 2 the effects of intracerebroventricular (icv) infusions o f pirenzepine
(M l receptor antagonist) were investigated in the same sustained attention task
used in Experiment 1. Different M l receptor antagonists were used in
Experiment 1 and Experiment 2 in order to test the generalizability o f any effects
of M l receptor blockade on attentional performance. ICV administration was
used to create widespread receptor blockade, while avoiding any peripheral
effects o f systemic administration. Widespread receptor blockade was important
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because only extensive loss o f cortical cholinergic inputs have been found to
disrupt performance in the standard task (McGaughy et al., 1996; Newman &
McGaughy, 2008). Administration o f pirenzepine was expected to disrupt
detection of visual signals, but not to affect accuracy on nonsignal trials. The lack
of effect o f dicyclomine and pirenzepine on trials with no signal presentation
suggests that M l receptor blockade does not disrupt the ability to respond based
upon the rules of the task, motoric functioning or motivation. This selective
pattern o f results has also been observed after lesions o f basal forebrain
corticopetal cholinergic neurons (McGaughy et al., 1996), so a similar pattern of
results would suggest that M l receptors critically contribute to attentional
processing mediated by the central cholinergic system.
Method
Experiment 1
Subjects
Subjects were nine male Long-Evans rats; weighing 151-175 g at the
beginning o f the experiment (Charles River Laboratories Inc., Wilmington, MA).
Animals were housed individually in hanging wire cages in a vivarium with a
14/10 h light/dark cycle (lights on 0600-2000). All behavioral testing occurred
during the light cycle between 0900 and 1200, for five or six days a week. Rats
were permitted to feed freely, but were water restricted on testing days, receiving
water during task performance and for 30 min following testing sessions. On
days the rats were not tested they were allowed free access to water overnight or
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for 1 h during the day. The experimental protocol was approved by the
Institutional Animal Care and Use Committee at the College of William and Mary.
Apparatus
Rats were trained in one of 12 chambers (Med Associates, Inc., Georgia,
VT) each enclosed within a sound-attenuating box. One side o f the chamber
contained two retractable levers, a water port with a dipper to deliver water (0.01
ml) situated between the two levers, and a centrally located panel light located
above the water port. A houselight was located in the back o f the chamber. The
behavioral testing programs and data collection were managed by a personal
computer utilizing Med-PC version IV software.
Behavioral training
The houselight remained illuminated throughout all testing sessions. In
the first stage o f training, the levers were extended throughout the session and the
dipper was raised following each lever press. However, following five
consecutive presses on a single lever, the other lever had to be pressed to receive
water access. The rule was included to attempt to prevent a lever bias. After
reaching a criterion of 120 lever presses per session for three sessions, rats were
trained to discriminate between signals ( I s illumination of the panel light) and
nonsignals (no illumination o f the panel light). After a signal or nonsignal, the
levers were extended into the chamber. The rules for a correct response were
counterbalanced across animals. For half the animals, following a signal, a press
on the left lever was considered a “hit” and the rat received water access. A
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response on the right lever was considered incorrect, scored as a “miss” and the
rat received no water. After a nonsignal, a press on the right lever was considered
correct, scored as a “correct rejection” and water was given, while pressing the
left lever was considered a “false alarm”. After a lever press, levers were
retracted. Failure to press either lever within 3 s was considered an “omission”.
Half o f the animals were trained based on these rules and the other half trained
with the reverse rules (e.g., right lever press correct after a signal and left lever
press correct after a nonsignal). The ITI varied (12+3 s) during training to
prevent the rats from anticipating the onset o f the next trial. Incorrect responses
were followed by a correction trial that was identical to the previous trial. Three
consecutive incorrect responses triggered a forced trial where only the correct
lever was extended into the chamber for 90 s. When the three consecutive errors
occurred on signal trials, the panel light remained illuminated for the duration of
the forced trial. Animals were trained in this task until they reached criterion o f
70% hits and 70% correct rejections for three consecutive sessions. In the next
level o f training the signal duration was reduced and varied within each session
(500, 100, or 25 ms). A session consisted o f 162 trials with an ITI o f 9 + 3 sec.
The signal duration and ITI were decreased to place higher demands on
attentional processing (McGaughy & Sarter, 1995). Animals were trained in this
version of the task to a criterion of 70% hits at the 500 ms and 70% correct
rejections for three consecutive sessions in order to move to the drug
administration phase o f the experiment.

15
Drug administration and behavioral testing

Dicyclomine was dissolved in saline and injected into the intraperitoneal
cavity in a volume on 1.0 ml/kg. The doses used were 0.625, 1.25, 2.50, 5.0
mg/kg o f dicyclomine. The dicyclomine solution was heated for approximately 5
min until the solution was visibly dissolved.
Rats each received five sessions with three different task manipulations:
standard task, short ITI, and distracter task. In the short ITI version o f the task,
the ITI was decreased to 4.5 + 3 sec. In the distracter task, the houselight flashed
on and off at 1 s intervals for the entire session. The order o f the task
manipulations and drug administration was randomly assigned to each rat. Rats
received each drug dose for all three task manipulations, for a total o f 15
injections. After an injection, animals were placed in the testing chamber and the
program was started. There was a 15 min delay between drug administration and
testing to allow the drug to take effect (Fomari, Moreira, & Oliveira, 2000).
Between drug administration days, rats returned to the standard task and were
required to meet a criterion o f 70% hits at the 500 ms signal and 70% correct
rejections before proceeding to the next drug administration day.
Behavioral measures
The number of hits, misses, correct rejections, false alarms, and omissions
were recorded for each testing session. Omissions were analyzed separately from
measures o f response accuracy.
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Statistical analysis
The effects o f the drug were analyzed separately for each task
manipulation. The relative number o f hits (percentage o f hits divided by 100) was
analyzed using a repeated-measures analysis o f variances (ANOVA) with the
factors o f signal duration and drug dose. The relative number of correct rejections
(percentage o f correct rejections divided by 100) was also analyzed using a
repeated-measures ANOVA. A repeated-measures ANOVA was also used to
analyze the number o f omissions. Data analyses were conducted with SPSS 15.0
for Windows (SPSS, Chicago, IL). P values were corrected with the Huynh-Feldt
procedure. An a level o f 0.05 was used to determine statistical significance.
Experiment 2
Subjects
Subjects were ten male Long-Evans rats (Charles River Laboratories Inc.,
Wilmington, MA). Animals were housed identically to those in Experiment 1.
Rats were also water restricted for the duration o f the experiment, receiving water
during task performance and for 30 min following testing sessions. The
experimental protocol was approved by the Institutional Animal Care and Use
Committee at the College o f William and Mary.
Apparatus and behavioral training
Animals were trained in the same chambers using the same procedure
prior to drug administration as in Experiment 1.
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Surgical procedures
Once animals met a criterion of 70% hits at the 500 ms and 70% correct
rejections for three consecutive sessions they moved to the surgery phase of the
experiment. Before surgery animals were anesthetized with an intraperitoneal
injection o f 90.0 mg/kg ketamine and 9.0 mg/kg xylazine. The head o f the rat was
shaved and then placed in a Kopf stereotaxic instrument. An incision was made
through the skin down the center o f the head to expose the skull. A hole was
drilled and the cannula (8 mm, 22 gauge) was placed into either the right (50% of
the rats) or left lateral ventricle at the following co-ordinates: AP = -0.8 mm
posterior, L = 1.6 mm lateral to bregma and V = -2.5 mm relative to bregma.
Three additional holes were drilled for supporting screws, one anterior to the
guide cannula and two posterior to the guide cannula. The guide cannula and
three supporting screws were covered in dental acrylic cement. Animals were
given acetaminophen (2.7 mg/ml) in their water bottle 24 h before surgery and 3
days following surgery for pain relief.
Post-surgical drug administration and behavioral training
The animals were allowed one week o f free water access after surgery
before returning to training. After returning to a water-deprivation schedule, rats
were required to maintain 70% hits and 70% correct rejections for 3 sessions
before drugs could be administered. All rats received infusions of: 0,10, 30, and
60 pg pirenzepine, dissolved into saline. Drug administration occurred via an
internal cannula that extended 1.0 mm below the guide cannula. Polyethylene

18
tubing connected the cannula to a 10 pi Hamilton syringe. The syringe was loaded
into a microinfusion pump (Pump II, Harvard Apparatus). Solutions were infused
at a rate o f 1.0 pl/min and the total volume injected was 2.5 pi. The infused
solution was allowed to diffuse for 1 min before replacing the infusion cannula
with dummy cannula to prevent clogging. There was a 10 min delay between
drug administration and testing to allow the drug to take effect (Aura et al., 1997).
Histology
Following completion o f the drug schedule, rats were anesthetized and
intracardially perfused at 300 mm Hg with 10% sucrose followed by 10%
formalin. Perfused brains were left overnight in formalin prior to being placed in
30% sucrose phosphate buffer for approximately three days. The brains were
frozen and sectioned in the coronal plane with a microtome (50 pm). The brain
sections were mounted on gelatin-coated slides and dried overnight before being
stained with cresyl violet and cover-slipped. The sections were then examined to
determine the placement o f the cannula tips.
Behavioral measures and statistical analysis
The same behavioral measures and statistical analysis used in Experiment
1 was used in Experiment 2.
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Results
Experiment 1
The data reported are from the nine rats that maintained stable
performance levels between drug administration sessions. The effects of
dicyclomine were analyzed separately for each task manipulation.
Standard task
A repeated-measures dose x signal duration ANOVA on the relative
number o f hits for the three signal durations on the standard task found a
significant main effect for signal duration (F(2, 16) = 142.74,/? < .001). Rats
exhibited signal duration-dependent accuracy, with the hit rate higher following
longer signal durations. A main effect o f dose was also observed with a decrease
in hits associated with an increase in the drug dose, (F(4,32) = 3.49, p = .018)
(Figure 1). A paired samples t test revealed a significant difference between
vehicle and the highest drug dose (5.0 mg/kg dicyclomine) (t(8) = 2.52,/? = .036).
A repeated-measures ANOVA for the relative number o f correct rejections
(Figure 2) or for omissions (Figure 3) found no significant main effects for dose.
Distracter task
A repeated-measures ANOVA found a significant main effect for signal
duration on the relative number o f hits (F(2,16) = 130.45,/? < .001), with a higher
degree of accuracy following the longest signal duration (Figure 4). No main
effect o f drug dose or signal duration x drug dose interaction was observed.
However, when the drug doses were averaged together and compared to vehicle a
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main effect o f drug was observed (F(l ,8) = 7.51, p = .025) as well as a dose x
signal duration interaction (F(2,16) = 146.08,/? —.034). A t test was performed at
each signal duration comparing vehicle to the average of the drug doses. O f those,
the 500 ms signal was the only signal duration to show a significant difference
(/(8) = 6.96,/? < .001). Further t tests at the 500 ms signal duration revealed
significant differences in hits when vehicle was compared to 0.625 mg/kg
dicyclomine (7(8) = 4.01,p = .004), 2.5 mg/kg dicyclomine (/(8) = 5.93,p < .001),
and 5.0 mg/kg dicylomine (^(8) =2.94,p = .019), but not 1.25 mg/kg dicylomine
(/(8) = 2.159 , /? > .05). A repeated-measures ANOVA found no significant main
effects for dose for the relative number o f correct rejections (Figure 5) or for
omissions (Figure 6).
Short ITI
A repeated-measures ANOVA found a significant main effect for signal
duration on the relative number o f hits for the three signal durations (F(2,16) =
147.42,/? < .001), with the hit rate higher following the longest signal duration.
For hits a significant interaction was found between drug dose and signal duration,
(F(8,64) = 3.05, p = .006) (Figure 7). A one-way ANOVA was performed at each
signal duration comparing drug dose. O f those, the 100 ms signal was the only
signal duration to show significant differences between the drug doses (F(4,32) =
3.83,/? = .016). A paired-samples t test revealed that hits were significantly
reduced following the 5.0 mg/kg dose when compared to vehicle (t(8) = 2.929, p
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= .019). No significant main effects for dose were found for the relative number
o f correct rejections (Figure 8) or for omissions (Figure 9).
Experiment 2
The data reported here are from the ten rats that maintained stable
performance levels between drug administration sessions and had correct cannula
placement. A repeated-measures dose x signal duration ANOVA on the relative
number o f hits for the three signal durations on the standard task found a
significant main effect for signal duration (F(2,18) = 99.9, p = .001). Rats
exhibited signal duration-dependent accuracy, with the hit rate higher following
longer signal durations. For hits, a significant interaction was found for signal
duration and dose (F(6,54) = 4.766, p = .001) (Figure 10). A one-way ANOVA
was performed at each signal duration comparing drug doses. The 500 ms signal
was the only signal duration to show significant differences between the drug
doses (F(3,27) = 5.485,/? = .006). A paired samples t-test compared the vehicle
dose with each drug dose at the 500 ms signal. The highest drug dose (60 pg
pirenzepine) significantly impaired performance when compared to vehicle (t(9) =
2.944, p = .016). No other significant effects were found for the hits. A repeatedmeasures ANOVA for the relative number o f correct rejections (Figure 11) or for
omissions (Figure 12) found no significant main effects for dose as a factor.
Discussion
The current experiments investigated the effects o f M l receptor blockade
on performance in an attention demanding visual discrimination task. Animals
were given M l receptor antagonists prior to performing a sustained attention task
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that required the discrimination o f a brief visual signal from a nonsignal.
Experiment 1 examined the effects of systemic administration of dicyclomine on
three task manipulations designed to vary the amount o f attentional demands
needed to complete the task. In the standard task, accuracy on the signal trials
was decreased following the highest dose o f dicyclomine. In the distracter task, at
the 500 ms signal duration, signal detection was disrupted following multiple
dicyclomine doses (0.625 mg/kg, 2.5 mg/kg, 5.0 mg/kg) compared to vehicle.
Under these conditions, the effects o f 1.25 mg/kg dose o f dicyclomine approached
statistical significance compared with vehicle. Finally, in the short ITI task
decreased signal detection was observed at the 100 ms signal duration at the
highest doses o f dicyclomine. In Experiment 2, icv administration of the M l
receptor antagonist pirenzepine decreased signal detection at the longest signal
duration (500 ms) at the highest dose (60 pg) when compared to vehicle.
In both experiments, no drug-induced deficits were found on accuracy
during the nonsignal trials as the number of correct rejections did not change
across dose. The ability to correctly reject nonsignals has been used previously in
attention tasks as an indicator that the subjects displayed no lever bias and were
continuing to respond based on the task rules (McGaughy et al., 1996). The
decrease in the number o f hits was not caused by a side bias because an increase
in the number o f relative correct rejections would have been expected if rats were
only pressing the miss/correct rejection lever. No severe motor deficits or effects
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on motivation for reward were caused by the drugs, as evidenced by the lack of
any significant drug-induced change in omissions.
In the standard task, systemic injection o f the highest dose o f dicyclomine
created a decrease in signal detection at all signal durations. Severe disruption of
visual processing seems unlikely to explain these deficits in signal detection
because accuracy remained signal duration dependent under all drug
administration conditions. The impairment in signal detection at all signal
durations following systemic M l receptor blockade was expected and is
consistent with the effects o f systemic muscarinic receptor blockade (Johnson &
Burk, 2006; McQuail & Burk, 2006). A separate group o f animals received an
M l receptor antagonist into the lateral ventricle to test whether the effects of
systemic M l receptor blockade were mediated centrally. Intraventricular
infusions o f an M l receptor antagonist produced similar, but not identical,
disruptions in signal detection compared to systemic administration. Specifically,
icv drug administration produced an accuracy that was only detected following
the 500 ms signal. The disruption o f performance at the 500 ms signal duration
after icv administration o f pirenzepine is similar to less extensive cortical
cholinergic deafferentation created by intracortical infusions of 192 IgG-saporin,
which produced loss o f only 40 to 60 percent o f cholinergic fibers in the anterior
two-thirds o f the cortex (McGaughy & Sarter, 1998). Similar to McGaughy and
Sarter (1998) pirenzepine administration may have only produced a moderate
impairment o f the cholinergic system, resulting in the pattern o f detection deficits
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only at the longest signal duration.

Icv administration o f pirenzepine may have

only produced a moderate impairment because the drug may not have diffused
completely throughout the brain. An increase in the pirenzepine dose may have
produced more substantial deficits in the detection o f signals and provided a
clearer idea o f the effects of the drug manipulation.
In the short ITI task signal detection was disrupted at the 100 ms signal
duration at the highest dose o f pirenzepine. The lack o f effect at the 25 ms signal
duration may be due to a floor effect. Furthermore, the hit rate following the 25
ms signal was relatively low in both experiments indicating that rats most
commonly responded as if no signal was presented on these trials. This relatively
low hit rate may have contributed to difficulty observing further drug-induced
declines in accuracy following the 25 ms signal.
In the distracter task, signal detection was disrupted at the 500 ms signal
duration. Additionally, performance was disrupted at low doses o f dicyclomine
administration, while in the standard and short ITI tasks signal detection was only
disrupted at the higher doses (see Figure 13 for a summary o f the effects of
pirenzepine on the standard and distracter task). The distracter task is more taxing
on the attentional system because the flashing houselight disrupts the animal’s
ability to discriminate between signals and nonsignals. This increase in
attentional demand may recruit different brain regions for performance which
explains why performance was disrupted at lower doses o f dicyclomine. Distinct
subregions in the cortex are implicated depending on the attentional demands
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(Dailey, Cardinal, Robbins, 2004). One subregion, the prefrontal cortex, is
important for maintenance o f attention in the presence of distraction (Newman &
McGaughy, 2008). Cholinergic lesions of the prefrontal cortex increased
susceptibility to irrelevant stimuli during attention task performance (Newman &
McGaughy, 2008). Other studies have shown that prefrontal cholinergic inputs
contribute to distracter-related processing in animals performing a sustained
attention task (Gill et al., 2000). Gill et al. (2000) demonstrated that increasing
attentional demand by presenting a visual distracter increased prefrontal cortical
neuronal firing rates. Removal o f cholinergic projections to the medial prefrontal
cortex decreased the firing rate o f prefrontal cortical neurons and attenuated the
frequency and amplitude of increased neuronal firing rates that were associated
with the response o f a distracter. In other words, the correlation between
prefrontal cortical neuron firing rates and attentional demand is dependent on the
integrity o f cholinergic inputs to the prefrontal cortex (Gill et al., 2000).
Moreover, blockade o f prefrontal cortical muscarinic receptors was found to
disrupt performance in the five choice serial reaction time task (Chudasama et al.,
2004). Infusions o f scopolamine, into the prefrontal cortex produced deficits
similar to those produced by basal forebrain cholinergic lesions. These findings,
along with the present data, suggest that muscarinic receptors within the
prefrontal cortex may be critical for mediating attentional performance,
particularly when irrelevant stimuli are presented.
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The above studies all illustrate the importance of ACh in the prefrontal
cortex under increased attentional demands. The present data offer some
indication that the M l receptors in the prefrontal cortex may be sensitive to low
doses o f dicyclomine. If these receptors are inhibited at low doses of dicyclomine,
higher doses will not be able to inhibit the receptors further and similar deficits
will be found at both high and low doses of the drug. The available literature
suggests that there are regional and layer-specific differences in M l and M2
receptors in the cerebral cortex, although exactly how these differences may
contribute to altered sensitivity to M l receptor antagonists remains unclear
(Lidow, Gallager, Rakic, & Goldman-Rakic, 1989). In the standard task, a higher
drug dose was needed to disrupt performance which suggests that prefrontal
cortical M l receptors may not be as critical for performance o f the standard
version o f this attention task. Previous research shows excitotoxic prefrontal
cortical lesions, which destroy a variety o f inputs to this region, disrupt decisional
processes necessary to complete the task (Miner, Ostrander, & Sarter, 1997).
However, prefrontal ACh is not needed for performance on the standard task
(Newman & McGaughy, 2008). Thus, dicyclomine may be affecting M l
receptors in other brain regions in the standard task. Similarly, the short ITI task
performance was only disrupted at high doses o f dicyclomine. The short ITI task
may not be as attentionally demanding as the distracter task, which is supported
by McGaughy & Sarter (1995) who found a high event rate did not disrupt

performance as greatly as a flashing houselight. Prefrontal cortical acetylcholine
is most likely not being recruited to perform the task with a shorter ITI.
It is thought that in the presence o f a distracter, top-down processing is
required to sustain attention and filter out background “noise” (Sarter, Givens,
Bruno, 2001). Top-down processing refers to knowledge driven mechanisms
designed to enhance the processing of relevant sensory input to facilitate
discrimination between targets and distracters (Kastner & Ungerleider, 2000).
The basal forebrain cholinergic system is proposed to contribute to the
functionally top-down processes in sustained attention (Sarter et al., 2001).
According to present hypotheses, when a visual distracter is introduced during
task performance, the basal forebrain cholinergic system becomes activated in
proportion to the level of attention required to maintain performance. When the
basal forebrain is activated, under conditions o f high attentional demand, a subset
o f neurons in the medial prefrontal cortex detect this change and elevate their
activity and subsequently project this enhanced activity to the posterior cortical
regions to modulate the processing o f signals (Nelson, Sarter, & Bruno, 2005).
This hypothesis is supported by lesion studies that have found bilateral infusions
o f 192 IgG-saporin into the medial prefrontal cortex resulted in selective
impairments in sustained attention (Newman & McGaughy, 2008). Signal
detection accuracy was disrupted during the presence o f a visual distracter, but
not under standard attentional conditions. The lack o f effect o f bilateral medial
prefrontal cortex cholinergic lesions on performance under standard attentional
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conditions suggests that medial prefrontal cortex cholinergic inputs may have less
o f a role in enhancing signal detection and more o f a role in filtering out irrelevant
stimuli. Loss o f cholinergic inputs to the posterior parietal cortex increases
response latencies, but does not affect accuracy, when the irrelevant flashing
houselight is presented in the present attention task (Broussard, Karelina, Sarter,
& Givens, 2009). Thus, it seems unlikely that the effects of M l receptor
antagonists in the present experiment, which decrease signal detection accuracy,
are mediated within the posterior parietal cortex.
The present experiment is consistent with previous studies that have found
cognitive deficits following M l receptor blockade. Disruptions in memory
performance have been reported after administration o f an M l receptor antagonist
(Bymaster et al., 1993; Aura et al., 1997; Anagnostaras et al., 2003), but the effect
on attention has not been studied. The present experiment found that blocking
M l receptors decreases accuracy in an attention demanding task and further
disrupts performance when attentional demands are increased. The disruption in
memory performance found in previous studies may be due to a disruption in
attentional capacity caused by blocking the M l receptor.
These results further support the role of the M l receptor in AD.
Improvements in cognition have been reported following the use of muscarinic
M l receptor agonists (Clader & Wang, 2005) while an impairment o f M l
mediated signaling may underlie the cognitive decline associated with the disease
(Tsang et al., 2007). However, Tsang et al. (2007) found that M l/G protein
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decoupling was correlated with reductions in PKC activity and NMDA receptor
density. They suggest postsynaptic cholinergic dysfunction may underlie the
cognitive features of AD. In addition, these data suggest that M l receptor
agonists may be beneficial during the early stages of AD, while M l/G protein
coupling is unaffected.
The current study was limited by the fact that dicyclomine was
administered systemically, so the drug could have had peripheral effects. In
addition, pirenzepine was administered into the lateral right or left ventricle so it
affected all brain regions, not just regions specialized for attention. It may be
beneficial to investigate the effects o f M l receptor blockade on specific areas in
the brain, such as the prefrontal cortex. Future studies could also investigate if
M l receptor agonists could attenuate the attentional impairments caused by
moderate impairment o f the cholinergic system.
In summary, M l receptor blockade decreased signal detection accuracy in
an attention task. Deficits in attention were observed following systemic
administration of dicyclomine. Additionally, when attentional demands were
increased deficits in signal detection were observed at lower doses o f pirenzepine
that did not affect performance in the standard task. Signal detection was also
disrupted following icv administration o f pirenzepine. The effects of
acetylcholine on attention seem to be mediated, in part, by the M l receptor. The
present data offer a starting point to understanding the effect of the M l receptor
on attention.
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Figure Captions

Figure 1. Relative hits across dicyclomine doses at each signal duration in the
standard task. Relative hits were significantly decreased following the 5.0 mg/kg
dicyclomine dose.
Figure 2. Relative correct rejections across dicyclomine doses in the standard task.
Correct rejections were not significantly affected by dicyclomine administration
at any dose.
Figure 3. The number o f omissions across drug doses in the standard task.
Omissions were not significantly affected by dicyclomine administration at any
dose.
Figure 4. Relative hits across dicyclomine doses at each signal duration in the
distracter task. Relative hits were significantly decreased at the 500 ms signal
duration following the 0.625, 2.5, and 5.0 mg/kg dicyclomine doses and
approaching significance at the 1.25 mg/kg dose. No other significant effects were
observed at the 25 and 100 ms signal duration.
Figure 5. Relative correct rejections across dicyclomine doses in the distracter
task. Correct rejections were not significantly affected by dicyclomine
administration at any dose.
Figure 6. The number o f omissions across drug doses in the distracter task.
Omissions were not significantly affected by dicyclomine administration at any
dose.
Figure 7. Relative hits across dicyclomine doses at each signal duration in the
short ITI task. Relative hits were significantly decreased at the 100 ms signal
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duration following the 5.0 mg/kg dicyclomine dose. No other significant effects
were observed at the 25 and 500 ms signal duration.
Figure 8. Relative correct rejections across dicyclomine doses in the short ITI
task. Correct rejections were not significantly affected by dicyclomine
administration at any dose.
Figure 9. The number o f omissions across drug doses in the short ITI task.
Omissions were not significantly affected by dicyclomine administration at any
dose.
Figure 10. Relative number o f hits across pirenzepine doses at each signal
duration in the standard task. Relative hits were significantly decreased at the 500
ms signal duration following the 60 pg pirenzepine dose. No other significant
effects were observed at the 25 and 100 ms signal duration.
Figure 11. Relative correct rejections across dicyclomine doses in the standard
task. Correct rejections were not significantly affected by dicyclomine
administration at any dose.
Figure 12. The number o f omissions across drug doses in the standard task.
Omissions were not significantly affected by pirenzepine administration at any
dose.
Figure 13. Relative hits were averaged across the various signal durations for
each dicyclomine dose in the standard and distracter task (Experiment 1). In the
standard task, relative hits decreased at the highest dicyclomine dose (5.0 mg/kg)
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while in the distracter task relative hits decreased across most doses (0.625, 2.5,
5.0 mg/kg).
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Figure 2.
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Figure 3.
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Figure 4.
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Figure 6.
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Figure 8.
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Figure 9.

Number of O m i s s i o n s

30 -

20

-

10

-

0

0.625

1.25

2.5

Dicyclomine dose (mg/kg)

5

51

Relative Hits

Figure 10.

0.4

-

0.2

-

0.0
0

10

30

Pirenzepine dose (fig)

60

52

Figure 11.
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Figure 12.
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Figure 13.
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